Amneal Pharmaceuticals Inc.

About Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals is dedicated to making healthy possible by challenging conventions and developing essential medicines. Their mission focuses on increasing access to affordable and innovative treatments to improve patient lives.

Products & Services

Generic Products:A broad portfolio of approximately 280+ generic pharmaceuticals aimed at providing affordable treatment options.

Specialty Products:Specialized medicines targeting specific health conditions with innovative solutions.

Biosciences:Innovative therapies in oncology and supportive care for cancer patients.

Naloxone Nasal Spray:A life-saving medication to increase access for opioid overdose reversal.

Brekiya (dihydroergotamine mesylate) Autoinjector:FDA-approved treatment for acute migraine and cluster headache episodes.

CREXONT (Carbidopa and Levodopa) Extended-Release Capsules:Treatment for Parkinson’s disease with extended-release formulation.

Specialties

Generic Pharmaceuticals Specialty Pharmaceuticals Biosimilars Oncology Parkinson’s Disease Treatment Complex Medicines Development First-to-File and First-to-Market Medicines

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 1800000000 MR: - FA: $1.800 billion FAN: 1800000000	D: 2025-07-21 FD: 2025-07-21	-

Debt Latest

2025-07-21

$1.8B

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Paul Meister

Chairman

C

Chirag Patel

Co-Founder and CEO

C

Chintu Patel

Co-Founder

D

Deb Autor

Director

J

J. Kevin Buchi

Director

J

Jeff George

Managing Partner of Maytal Capital

View 24 more team members with Pro

Unlock Full Team Directory

Recent News